PATH BGC— 510(k) K260938

Substantially Equivalent

Crossroads Neurovascular, Inc.

FDA 510(k) clearance K260938 for PATH BGC, Substantially Equivalent on 2026-04-15. Applicant: Crossroads Neurovascular, Inc..

Clearance details

Applicant: Crossroads Neurovascular, Inc.
Product code: Code QJP
Advisory panel: Cardiovascular
Date received: 2026-03-20
Decision date: 2026-04-15
Decision: Substantially Equivalent
Clearance type: Special
Location: Lake Forest, CA, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code QJP

product code QJP

Death: 43
Injury: 233
Malfunction: 1,010
Total: 1,286

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.